| Prefrontal transcranial direct current stimulation for treatment of schizophrenia with predominant negative symptoms: a double-blind, sham-controlled proof-of-concept study U Palm, D Keeser, A Hasan, MJ Kupka, J Blautzik, N Sarubin, ... Schizophrenia bulletin 42 (5), 1253-1261, 2016 | 136 | 2016 |
| Effects of social exclusion on emotions and oxytocin and cortisol levels in patients with chronic depression A Jobst, L Sabass, A Palagyi, C Bauriedl-Schmidt, MC Mauer, N Sarubin, ... Journal of psychiatric research 60, 170-177, 2015 | 131 | 2015 |
| Lower oxytocin plasma levels in borderline patients with unresolved attachment representations A Jobst, F Padberg, MC Mauer, T Daltrozzo, C Bauriedl-Schmidt, ... Frontiers in Human Neuroscience 10, 125, 2016 | 88 | 2016 |
| Neuroticism and extraversion as mediators between positive/negative life events and resilience N Sarubin, M Wolf, I Giegling, S Hilbert, F Naumann, D Gutt, A Jobst, ... Personality and Individual Differences 82, 193-198, 2015 | 87 | 2015 |
| Erste analyse der psychometrischen Eigenschaften und Struktur der deutschsprachigen 10-und 25-Item version der Connor-Davidson Resilience Scale (CD-RISC) N Sarubin, D Gutt, I Giegling, M Bühner, S Hilbert, O Krähenmann, M Wolf, ... Zeitschrift für Gesundheitspsychologie, 2015 | 84 | 2015 |
| The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic–pituitary–adrenal-axis activity: A randomized trial N Sarubin, C Nothdurfter, C Schüle, M Lieb, M Uhr, C Born, ... Journal of psychiatric research 53, 76-83, 2014 | 73 | 2014 |
| Enhancing neurosteroid synthesis–relationship to the pharmacology of translocator protein (18 kDa)(TSPO) ligands and benzodiazepines L Wolf, A Bauer, D Melchner, H Hallof-Buestrich, P Stoertebecker, E Haen, ... Pharmacopsychiatry 48 (02), 72-77, 2015 | 70 | 2015 |
| Versorgung psychisch kranker Erwachsener in Deutschland R Nübling, T Bär, K Jeschke, M Ochs, N Sarubin, J Schmidt Psychother J 4, 389-397, 2014 | 65 | 2014 |
| The role of self-esteem in depression: A longitudinal study S Hilbert, S Goerigk, F Padberg, A Nadjiri, A Übleis, A Jobst, ... Behavioural and cognitive psychotherapy 47 (2), 244-250, 2019 | 50 | 2019 |
| Attachment representations, patterns of emotion regulation, and social exclusion in patients with chronic and episodic depression and healthy controls C Bauriedl-Schmidt, A Jobst, M Gander, E Seidl, L Sabaß, N Sarubin, ... Journal of Affective Disorders 210, 130-138, 2017 | 44 | 2017 |
| Oxytocin plasma levels predict the outcome of psychotherapy: A pilot study in chronic depression A Jobst, L Sabass, D Hall, B Brücklmeier, A Buchheim, J Hall, N Sarubin, ... Journal of affective disorders 227, 206-213, 2018 | 41 | 2018 |
| The influence of the response format in a personality questionnaire: An analysis of a dichotomous, a Likert-type, and a visual analogue scale. S Hilbert, H Kuechenhoff, N Sarubin, T TOYO NAKAGAWA, M Buehner TPM: Testing, Psychometrics, Methodology in Applied Psychology 23 (1), 2016 | 41 | 2016 |
| Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression N Sarubin, C Nothdurfter, C Schmotz, AM Wimmer, J Trummer, M Lieb, ... Psychoneuroendocrinology 39, 141-151, 2014 | 41 | 2014 |
| Transcranial direct current stimulation (tDCS) for treatment of phobic postural vertigo: an open label pilot study U Palm, V Kirsch, H Kübler, N Sarubin, D Keeser, F Padberg, M Dieterich European archives of psychiatry and clinical neuroscience 269, 269-272, 2019 | 36 | 2019 |
| The cytokine IL‐17A as a marker of treatment resistance in major depressive disorder? C Nothdurfter, VM Milenkovic, N Sarubin, S Hilbert, A Manook, J Weigl, ... European Journal of Neuroscience 53 (1), 172-182, 2021 | 34 | 2021 |
| A systematic review of mechanisms of change in body-oriented yoga in major depressive disorders K Meister, G Juckel Pharmacopsychiatry 51 (03), 73-81, 2018 | 33 | 2018 |
| The sex-dependent role of the glucocorticoid receptor in depression: variations in the NR3C1 gene are associated with major depressive disorder in women but not … N Sarubin, S Hilbert, F Naumann, P Zill, AM Wimmer, C Nothdurfter, ... European archives of psychiatry and clinical neuroscience 267, 123-133, 2017 | 33 | 2017 |
| Macrophage-derived chemokine: a putative marker of pharmacological therapy response in major depression? VM Milenkovic, N Sarubin, S Hilbert, TC Baghai, F Stöffler, JM Lima-Ojeda, ... Neuroimmunomodulation 24 (2), 106-112, 2017 | 23 | 2017 |
| Distinct trajectories of response to prefrontal tDCS in major depression: results from a 3-arm randomized controlled trial SA Goerigk, F Padberg, M Bühner, N Sarubin, TS Kaster, ZJ Daskalakis, ... Neuropsychopharmacology 46 (4), 774-782, 2021 | 21 | 2021 |
| Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic–pituitary–adrenal-axis activity in relation to antidepressant effectiveness C Nothdurfter, C Schmotz, N Sarubin, TC Baghai, A Laenger, M Lieb, ... Journal of psychiatric research 52, 15-20, 2014 | 21 | 2014 |
